REGENERON PHARMACEUTICALS INC (REGN) - Price, trends, fundamentals and chart - Passport to Wall Street

REGENERON PHARMACEUTICALS INC (NASDAQ: REGN)

Overview

current price

$625.60

$625.60

change

8.60 | 1.39%

8.60 | 1.39%

Yesterday's Close

617.00

open

613.53

volume

0.90 M

30d. avg volume.

0.94 M

1 day

610.10 - 628.00

52 weeks

615.00 - 1,211.20

p/e

16.09

beta

0.4366

market cap

66.33 B

dividend yield

0.57%

Industry

-

News and Commentary

Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst Wednesday, Johnson & Johnson (...

After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stol... U.S. drug wholesaler Cencora Inc (

AI Integration In Biotech & Pharma: Companies Positioned To Benefit The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug dis...

$1 Billion Deal For Moderna To Expand Product Pipeline In China The defensive stocks sector has been underperforming most - if not all - of the remaining cyclical sectors in the U.S. economy. These preferences come from underlying dynamics in...

FDA Pulls Authorization for GSK Antibody Drug Ineffective Against New Omicron Strain The U.S. Food and Drug Administration (FDA) has withdrawn its authorization for GlaxoSmithKline plc's

FDA Withdraws Authorization for Regeneron and Eli Lilly Antibody Treatments For Use The U.S. Food and Drug Administration (FDA) has withdrawn its authorization for monoclonal antibody treatments manufactured by Regeneron

Regeneron is Working on New Antibody Therapy for Omicron, Rival Therapies Show Mixed Results Against... Following lackluster data on the effectiveness of its COVID antibody therapy against the high mutated Omicron variant, Regeneron

October 26 Market Update Global investors on Tuesday digested new data, policy statements, and earnings reports. In Europe, the British FTSE rose 0.76%, the German DAX climbed 1.01%, the French CAC rose...

AstraZeneca's Antibody Therapy is 77% Effective at Preventing COVID Symptoms in Late-Stage Trial AstraZeneca's (AZN&nbsp...

Regeneron Says Antibody Cocktail Can Prevent COVID Infection Regeneron Pharmaceuticals (RE...

StockTwits

StockTwits